Anchorage Capital Group, L.L.C. 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Anchorage Capital Group, L.L.C. disclosed 2 US equity positions worth $88.6m in its Q4 2025 13F filing. The largest position was S at 83.6% of the reported book. Against the Q3 2025 filing, it opened 0 new positions, added to 0 and reduced 0 among the top 2 holdings.
What did Anchorage Capital Group, L.L.C. own in Q4 2025? Top 2 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | S SENTINELONE INC | Technology | 83.6% | $74.1m | 4,937,053 | 0% | held |
| 2 | DNA GINKGO BIOWORKS HOLDINGS INC | 16.4% | $14.5m | 1,746,363 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.